Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 7
Submit an article Journal homepage
127
Views
16
CrossRef citations to date
0
Altmetric
Letters to the Editor

Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha

Michael Robert Humphreys Department of Medical Oncology and Hematalogy, Princess Margaret HospitalCorrespondence[email protected]
,
Maria Cino Department of Gastroenterology, Toronto Western Hospital
,
Ian Quirt Department of Medical Oncology and Hematalogy, Princess Margaret Hospital
,
David Barth Department of Medical Oncology and Hematalogy, Princess Margaret Hospital; Department of Pathology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
&
Vishal Kukreti Department of Medical Oncology and Hematalogy, Princess Margaret Hospital
Pages 1420-1423 | Received 21 Mar 2008, Accepted 29 Mar 2008, Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Meenakshi Bewtra & James D Lewis. (2010) Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 621-631.
Read now

Articles from other publishers (15)

Robert N. Stuver, Mwanasha Merrill & Salvia Jain. 2021. The Peripheral T‐Cell Lymphomas. The Peripheral T‐Cell Lymphomas 225 234 .
Daniella Klebaner, Divya Koura, Dimitrios Tzachanis, Edward D. Ball, Steven Horwitz & Aaron M. Goodman. (2020) Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 431-437.e2.
Crossref
Nalini Bansal, Ankush Pawar, Pankaj Puri & Subrat Acharya. (2020) Hepatosplenic T-cell lymphoma: A clinical diagnostic challenge. International Journal of Clinicopathological Correlation 4:1, pages 10.
Crossref
Akira Satou, Toyonori Tsuzuki & Shigeo Nakamura. (2019) Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype. Journal of Clinical and Experimental Hematopathology 59:2, pages 56-63.
Crossref
Mariko Yabe, L. Jeffrey Medeiros, Yahya Daneshbod, Masoud Davanlou, Carlos E. Bueso-Ramos, Elisa J. Moran, Ken H. Young & Roberto N. Miranda. (2017) Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor–α inhibitor therapy and literature review. Annals of Diagnostic Pathology 26, pages 16-22.
Crossref
Maartje M van de Meeberg, Lauranne A A P Derikx, Harm A M Sinnige, Peet Nooijen, D Lucette Schipper & Loes H C Nissen. (2016) Hepatosplenic T-cell lymphoma in a 47-year-old Crohn’s disease patient on thiopurine monotherapy. World Journal of Gastroenterology 22:47, pages 10465.
Crossref
Saranya A Selvaraj, Elizabeth Chairez, Lisa M Wilson, Mark Lazarev, Eric B Bass & Susan Hutfless. (2013) Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma. Systematic Reviews 2:1.
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Wayne W. Grody. 2013. Atlas of Hematopathology. Atlas of Hematopathology 539 546 .
Andrés J.M. Ferreri, Silvia Govi & Stefano A. Pileri. (2012) Hepatosplenic gamma-delta T-cell lymphoma. Critical Reviews in Oncology/Hematology 83:2, pages 283-292.
Crossref
Chang-li Lu, Yuan Tang, Qun-pei Yang, Mi Wang, Sha Zhao, Cheng-feng Bi, Neng-gang Jiang, Wen-yan Zhang, Jian-ping Liu, Xia Xu & Wei-ping Liu. (2011) Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of17 Chinese cases. Human Pathology 42:12, pages 1965-1978.
Crossref
Sherrie L. Perkins. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology 429 464 .
David S. Kotlyar, Mark T. Osterman, Robert H. Diamond, David Porter, Wojciech C. Blonski, Mariusz Wasik, Sami Sampat, Manuel Mendizabal, Ming V. Lin & Gary R. Lichtenstein. (2011) A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 9:1, pages 36-41.e1.
Crossref
Philippe Gaulard. 2011. Hematopathology. Hematopathology 532 540 .
Anne Thai & Thomas Prindiville. (2010) Hepatosplenic T-cell lymphoma and inflammatory bowel disease. Journal of Crohn's and Colitis 4:5, pages 511-522.
Crossref
Mark G. Ochenrider, David J. Patterson & David M. Aboulafia. (2010) Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review. Clinical Lymphoma Myeloma and Leukemia 10:2, pages 144-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.